Laurie Sherman

5.4k citations
41 papers · 1.9k indexed · 1 hit paper · h-index 15
Topics
Acute Myeloid Leukemia Research (13 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers)Chronic Myeloid Leukemia Treatments (10 papers)

In The Last Decade

Laurie Sherman

41 papers receiving 1.8k citations

Hit Papers

Improved survival with MEK Inhibition in BRAF-mutated mel...201220262016202120122505007501000

Peers

Laurie Sherman
Comparison fields: 5 of 81
  • Molecular Biology 1.2k
  • Oncology 1.0k
  • Pulmonary and Respiratory Medicine 474
  • Pathology and Forensic Medicine 204
  • Cancer Research 188
Replace Chenghua Xia with:
Chenghua Xia United States
Emily Chan United States
Nicoletta Brega United States
Amrita Desai United States
Jeff Sosman United States
Tinya J. Abrams United States
Richard C. Chao United States
Fawn Qian United States
Remy B. Verheijen Netherlands
Leslie B. Lee United States
Laurie Sherman relative to Chenghua Xia United States Chenghua Xia's profile →
Citations per field
00.5×5.4×
Chenghua Xia · 1×
Citations per year

Countries citing papers authored by Laurie Sherman

Since Specialization
Citations

This map shows the geographic impact of Laurie Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Sherman more than expected).

Fields of papers citing papers by Laurie Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Sherman. The network helps show where Laurie Sherman may publish in the future.

Co-authorship network of co-authors of Laurie Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Sherman. A scholar is included among the top collaborators of Laurie Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Sherman. Laurie Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 4
5 4
6 7
7 80
8 5
9 38
10 8
11
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Groupbreakdown →
1071
12 31
13 24
14 2
15
A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects
6
16 49
17 4
18 114
19 24
20 38

About Laurie Sherman

Laurie Sherman is a scholar working on Genetics, Hematology and Oncology, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Oncology (1.0k citations), Hepatology (157 citations) and Molecular Biology (1.2k citations). Laurie Sherman has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Frank Wu, Dirk Schadendorf, Michelle Casey, Paul Nathan, Mohammed Milhem, Peter Hersey, Piotr Rutkowski, Keith T. Flaherty, James Larkin and Lev Demidov. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026